![Mark Germain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Germain
Président chez
BIONDVAX PHARMACEUTICALS LTD
Fortune : - $ au 31/05/2026
Profil
Mark S.
Germain was the founder of Niagen Bioscience, Inc. (1999, Independent Non-Executive Director) and The Aentib Group (2014, Managing Director).
Current jobs include Chairman at Amphioxus Cell Technologies, Inc., Chairman at Scinai Immunotherapeutics Ltd. (2019), Director at Omnimmune Corp.
(2006), Managing Director at The Olmsted Group, and Managing Director at The Aentib Group, Inc. (2014).
Former jobs include Chairman at Stem Cell Innovations, Inc., Chairman at Collexis Holdings, Inc., Chairman at Omnimmune Holdings, Inc., Director at Interferon Sciences, Inc. (2006), Director at Wellsford Real Properties, Inc., Independent Director at Pluri, Inc. (2007-2022), Director at Intellect Neurosciences, Inc., Director at ChromaDex, Inc. (1992-2008), Director at Reis, Inc. (1997-2008), Trustee at Wellsford Residential Property Trust (1992-1997), and Vice President-Product Support at Nortrax, Inc. Education includes a graduate degree from New York University School of Law (1975).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Mark Germain
| Sociétés | Poste | Début |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Président | 30/09/2019 |
The Aentib Group, Inc. | Corporate Officer/Principal | 01/01/2014 |
Omnimmune Corp.
 Omnimmune Corp. Medical/Nursing ServicesHealth Services Develops cancer treatment | Directeur/Membre du Conseil | 01/01/2006 |
The Olmsted Group | Corporate Officer/Principal | - |
Amphioxus Cell Technologies, Inc.
 Amphioxus Cell Technologies, Inc. BiotechnologyHealth Technology Manufactures biological drug discovery products | Président | - |
The Aentib Group
 The Aentib Group Investment ManagersFinance Functions as an venture capital firm | Fondateur | 01/05/2014 |
Anciens postes connus de Mark Germain
| Sociétés | Poste | Fin |
|---|---|---|
| PLURI INC. | Directeur/Membre du Conseil | 21/06/2022 |
| NIAGEN BIOSCIENCE, INC. | Fondateur | 20/04/2015 |
ChromaDex, Inc.
 ChromaDex, Inc. Miscellaneous Commercial ServicesCommercial Services Supplies phytochemical reference standards | Directeur/Membre du Conseil | 15/07/2008 |
| ░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Mark Germain
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Interferon Sciences, Inc.
 Interferon Sciences, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures, and sells pharmaceutical products | Health Technology |
Wellsford Residential Property Trust
 Wellsford Residential Property Trust Real Estate Investment TrustsFinance Operates as a real estate investment trust | Finance |
Wellsford Real Properties, Inc.
 Wellsford Real Properties, Inc. Real Estate DevelopmentFinance Invests in, constructs, and sells real estate property | Finance |
Pluri, Inc.
 Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Intellect Neurosciences, Inc.
 Intellect Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutic agents for the treatment and prevention of neurodegenerative conditions | Health Technology |
Omnimmune Corp.
Omnimmune Corp. Medical/Nursing ServicesHealth Services Develops cancer treatment | Health Services |
ChromaDex, Inc.
ChromaDex, Inc. Miscellaneous Commercial ServicesCommercial Services Supplies phytochemical reference standards | Commercial Services |
Nortrax, Inc.
 Nortrax, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures industrial and construction equipment | Producer Manufacturing |
Stem Cell Innovations, Inc.
 Stem Cell Innovations, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts pharmacological research based on stem cells | Commercial Services |
Amphioxus Cell Technologies, Inc.
Amphioxus Cell Technologies, Inc. BiotechnologyHealth Technology Manufactures biological drug discovery products | Health Technology |
Reis, Inc.
 Reis, Inc. Data Processing ServicesTechnology Services Operates as a commercial real estate data and analytics firm that offers market intelligence, comparable, vacancy rates and valuation estimates | Technology Services |
Collexis Holdings, Inc.
 Collexis Holdings, Inc. Information Technology ServicesTechnology Services Engages in the development of software solutions | Technology Services |
The Olmsted Group | |
Chromadex Corp.
 Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
Omnimmune Holdings, Inc.
 Omnimmune Holdings, Inc. BiotechnologyHealth Technology Provides integrating complementary cancer therapeutic, diagnostic and prognostic technologies | Health Technology |
Scinai Immunotherapeutics Ltd.
 Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Aentib Group, Inc. | |
The Aentib Group
The Aentib Group Investment ManagersFinance Functions as an venture capital firm | Finance |
